United Natural Foods’ Objective Deemed IRRATIONALLY HIGH and 4 Stock Analyses to Notice Today

Splunk (NYSE:SPLK): According to Credit Suisse, Splunk’s strong July quarter results indicated increased penetration with existing customers and is encouraged by traction with larger deals. Shares have an Outperform rating.

Investing Insights: Wall Street Brief: Amazon and Nokia EXCLUDE Google, Apple LOSES.

Life Technologies Corporation (NASDAQ:LIFE): Credit Suisse stated that Life Technologies’ partnership with Sino Biological adds an established customer network as well as a strong entry into China’s eCommerce business. Shares have an Outperform rating and a $53 price target.

CIENA Corp. (NASDAQ:CIEN): Credit Suisse recommends using weakness in Ciena as an opportunity to buy. The firm thinks that the disappointing Q3 shortfall and guidance was caused by transitory project delays at AT&T (NYSE:T) and Verizon (NYSE:VZ). The firm gives shares an Outperform rating and a $22 price target, down from $25.

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD): Following the FDA’s approval of Ironwood’s Linzess for certain cases of irritable bowel syndrome and constipation, Cantor does not expect that the drug will become profitable until 2019. The firm anticipates that other research firms will become more negative regarding the stock, and Cantor keeps a Sell rating on the shares.

United Natural Foods, Inc. (NASDAQ:UNFI): Cantor does not believe that United Natural Foods will reach its long-term annual free cash flow objective of $35 million to $55 million during FY12. The firm believes that the company’s valuation is irrationally high, and it keeps a Sell rating on the stock.

Don’t Miss: Here’s Why the News Gets BAD for Facebook.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>